Caitong International Asset Management Co., LTD Novavax Inc Transaction History
Caitong International Asset Management Co., LTD
- $144 Billion
- Q3 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Novavax Inc stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 1,333 shares of NVAX stock, worth $9,291. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,333
Previous 62
2050.0%
Holding current value
$9,291
Previous $391,000
2855.75%
% of portfolio
0.01%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NVAX
# of Institutions
311Shares Held
95.7MCall Options Held
5.7MPut Options Held
9.06M-
Vanguard Group Inc Valley Forge, PA15.2MShares$106 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$82.6 Million0.0% of portfolio
-
Shah Capital Management11.8MShares$82.3 Million45.37% of portfolio
-
State Street Corp Boston, MA7.2MShares$50.2 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY4.27MShares$29.8 Million0.02% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $545M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...